Zacks' Senior Life Sciences Analyst John Vandermosten initiates on #ActiniumPharmaceuticals with a $4.00 price target.
youtube.com/shorts/Gh-GB...
Initiation: tinyurl.com/bdj6rjtm
$ATNM #NuclearMedicine #Radiopharmaceuticals #Oncology #AML #TargetedRadiotherapy #Biotech #CancerResearch

🚀 Zacks Small Cap Research - ATNM: Initiating Coverage – Diversified Nuclear Medicine Portfolio
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-atnm-initiating-coverage-diversified-nuclear-medicine-portfolio/
#ActiniumPharmaceuticals #ATNM #ATNM400 #IomabB #I